Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00041093Phase 2Completed
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Principalinvestigator
NCT00113373Phase 2Completed
Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Russell Schilder

Gynecologic Oncology Group

Related
5 trials

Shared therapeutic areas:

Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer

Worked with same sponsors:

Gynecologic Oncology GroupNational Cancer Institute (NCI)
Similarity Score15%

Amy D. Tiersten, MD

Herbert Irving Comprehensive Cancer Center

Related
4 trials

Shared therapeutic areas:

Primary Peritoneal Cavity Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Robert Kreitman, MD

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Primary Peritoneal Cavity Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Recurrent Ovarian Epithelial Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Brigitte E. Miller, MD

Wake Forest University Health Sciences

Related
7 trials

Shared therapeutic areas:

Primary Peritoneal Cavity Cancer

Worked with same sponsors:

Gynecologic Oncology GroupNational Cancer Institute (NCI)
Similarity Score8%

Lee M. Krug, MD

Memorial Sloan Kettering Cancer Center

Related
7 trials

Shared therapeutic areas:

Primary Peritoneal Cavity Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Carol Aghajanian, MD

Memorial Sloan Kettering Cancer Center

Related
5 trials

Shared therapeutic areas:

Primary Peritoneal Cavity Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Peter G. Rose, MD

The Cleveland Clinic

Related
4 trials

Shared therapeutic areas:

Primary Peritoneal Cavity Cancer

Worked with same sponsors:

Gynecologic Oncology GroupNational Cancer Institute (NCI)
Similarity Score8%

Lupe Salazar

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
6 trials

Shared therapeutic areas:

Recurrent Ovarian Epithelial Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00041093Phase 2PrincipalInvestigator

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Completed
NCT00113373Phase 2PrincipalInvestigator

Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer

Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Completed

All 2 trials loaded